RE:RE:RE:RE:It's TimeDDO, I agree, and Osiris, I have absolutely nothing against your shorting here.. the market in my opinion is fairly priced based on the risk/return, it's sitting at a level right now where people can still take some off the table or can still add depending on how much exposure they want to the risk/return; you're on the other side and it's okay because our risk profiles are actually similar at this point (except the fact i'm far longer than you are short).
Anyways, with Xandar and the burn rate, this quarter will be far different. CF's from all 4 revenue groups will be far higher thanks in large to partial payments received from the 3.2M project and all the additional InsightPro deals signed in Q3. Furhtermore, I believe somewhere in the past they mentioned R&D costs for the time being were basically brought to zero once NextMAP came online, so that drops op costs as thats where they are lumped in with all the way through until q2 somewhere. Furthermore, the co has an accum deficit of 226 mil and still only has 132m shares f.d. by my count, and issuing more warrants exerciseable around .50 could be a bullet being loaded into the chamber, but those won't impact us in the case the deal is closed. But, it'll likely be a bullet for if the extension stretches deep into December due to this quarters expected increase in CFO and rev.
I'm in agreement with ddo as well about market sentiment, and to me that's the reason why I don't care whose shorting or whose bashing. The Market has made it's mind up and everyone's willing to wait and hold for the time being. The bolemia level is .50 right now, anything over and there's a purge, anything under gets eaten back up.